Selected research
Market Structure
Global Cold and Flu Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Cold and Flu Supplement market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Cold and Flu Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cold and Flu Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cold and Flu Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Cold and Flu Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cold and Flu Supplement include Pfizer, GlaxoSmithKline, Wakunaga of America, The Vitamin Shoppe, NOW Foods, Nordic Naturals, Neurobiologix, Klaire Labs and Himalaya Global Holdings, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Cold and Flu Supplement market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cold and Flu Supplement and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cold and Flu Supplement revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cold and Flu Supplement market size, projected growth trends, production technologies, key applications, and end-use industries.
Cold and Flu Supplement Segment by Company
Pfizer
GlaxoSmithKline
Wakunaga of America
The Vitamin Shoppe
NOW Foods
Nordic Naturals
Neurobiologix
Klaire Labs
Himalaya Global Holdings
Flora
FineVine
Dr. Willmar Schwabe GmbH
Cold and Flu Supplement Segment by Type
Herbal Extracts
Natural Molecules
Vitamins and Minerals
Others
Cold and Flu Supplement Segment by Application
Online
Offline
Cold and Flu Supplement Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cold and Flu Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cold and Flu Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cold and Flu Supplement.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cold and Flu Supplement in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cold and Flu Supplement industry.
Chapter 3: Detailed analysis of Cold and Flu Supplement companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cold and Flu Supplementrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Herbal Extracts
- Natural Molecules
- Vitamins and Minerals
- Others
Applications
- Online
- Offline
Companies covered
- Pfizer
- GlaxoSmithKline
- Wakunaga of America
- The Vitamin Shoppe
- NOW Foods
- Nordic Naturals
- Neurobiologix
- Klaire Labs
- Himalaya Global Holdings
- Flora
- FineVine
- Dr. Willmar Schwabe GmbH
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Cold and Flu Supplement Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Herbal Extracts
- 1.2.3 Natural Molecules
- 1.2.4 Vitamins and Minerals
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Cold and Flu Supplement Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Online
- 1.3.3 Offline
- 1.4 Global Market Growth Prospects
- 1.5 Global Cold and Flu Supplement Growth Trends by Region
- 1.5.1 Global Cold and Flu Supplement Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Cold and Flu Supplement Market Size by Region (2021-2026)
- 1.5.3 Cold and Flu Supplement Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Cold and Flu Supplement Market Dynamics
- 2.1 Cold and Flu Supplement Industry Trends
- 2.2 Cold and Flu Supplement Industry Drivers
- 2.3 Cold and Flu Supplement Industry Opportunities and Challenges
- 2.4 Cold and Flu Supplement Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Cold and Flu Supplement Revenue by Company (2021-2026)
- 3.2 Global Cold and Flu Supplement Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Cold and Flu Supplement Key Company Head office and Area Served
- 3.4 Global Cold and Flu Supplement Company, Product Type & Application
- 3.5 Global Cold and Flu Supplement Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Cold and Flu Supplement Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Cold and Flu Supplement Players Market Share by Revenue in 2025
- 3.6.3 2025 Cold and Flu Supplement Tier 1, Tier 2, and Tier 3
4 Cold and Flu Supplement Market by Type
- 4.1 Global Cold and Flu Supplement Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Cold and Flu Supplement Market Size by Type (2021-2032)
- 4.3 Global Cold and Flu Supplement Market Size Share by Type (2021-2032)
5 Cold and Flu Supplement Market by Application
- 5.1 Global Cold and Flu Supplement Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Cold and Flu Supplement Market Size by Application (2021-2032)
- 5.3 Global Cold and Flu Supplement Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Pfizer
- 6.1.1 Pfizer Company Information
- 6.1.2 Pfizer Business Overview
- 6.1.3 Pfizer Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Pfizer Cold and Flu Supplement Product Portfolio
- 6.1.5 Pfizer Recent Developments
- 6.2 GlaxoSmithKline
- 6.2.1 GlaxoSmithKline Company Information
- 6.2.2 GlaxoSmithKline Business Overview
- 6.2.3 GlaxoSmithKline Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 GlaxoSmithKline Cold and Flu Supplement Product Portfolio
- 6.2.5 GlaxoSmithKline Recent Developments
- 6.3 Wakunaga of America
- 6.3.1 Wakunaga of America Company Information
- 6.3.2 Wakunaga of America Business Overview
- 6.3.3 Wakunaga of America Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Wakunaga of America Cold and Flu Supplement Product Portfolio
- 6.3.5 Wakunaga of America Recent Developments
- 6.4 The Vitamin Shoppe
- 6.4.1 The Vitamin Shoppe Company Information
- 6.4.2 The Vitamin Shoppe Business Overview
- 6.4.3 The Vitamin Shoppe Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 The Vitamin Shoppe Cold and Flu Supplement Product Portfolio
- 6.4.5 The Vitamin Shoppe Recent Developments
- 6.5 NOW Foods
- 6.5.1 NOW Foods Company Information
- 6.5.2 NOW Foods Business Overview
- 6.5.3 NOW Foods Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 NOW Foods Cold and Flu Supplement Product Portfolio
- 6.5.5 NOW Foods Recent Developments
- 6.6 Nordic Naturals
- 6.6.1 Nordic Naturals Company Information
- 6.6.2 Nordic Naturals Business Overview
- 6.6.3 Nordic Naturals Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Nordic Naturals Cold and Flu Supplement Product Portfolio
- 6.6.5 Nordic Naturals Recent Developments
- 6.7 Neurobiologix
- 6.7.1 Neurobiologix Company Information
- 6.7.2 Neurobiologix Business Overview
- 6.7.3 Neurobiologix Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Neurobiologix Cold and Flu Supplement Product Portfolio
- 6.7.5 Neurobiologix Recent Developments
- 6.8 Klaire Labs
- 6.8.1 Klaire Labs Company Information
- 6.8.2 Klaire Labs Business Overview
- 6.8.3 Klaire Labs Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Klaire Labs Cold and Flu Supplement Product Portfolio
- 6.8.5 Klaire Labs Recent Developments
- 6.9 Himalaya Global Holdings
- 6.9.1 Himalaya Global Holdings Company Information
- 6.9.2 Himalaya Global Holdings Business Overview
- 6.9.3 Himalaya Global Holdings Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Himalaya Global Holdings Cold and Flu Supplement Product Portfolio
- 6.9.5 Himalaya Global Holdings Recent Developments
- 6.10 Flora
- 6.10.1 Flora Company Information
- 6.10.2 Flora Business Overview
- 6.10.3 Flora Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Flora Cold and Flu Supplement Product Portfolio
- 6.10.5 Flora Recent Developments
- 6.11 FineVine
- 6.11.1 FineVine Company Information
- 6.11.2 FineVine Business Overview
- 6.11.3 FineVine Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 FineVine Cold and Flu Supplement Product Portfolio
- 6.11.5 FineVine Recent Developments
- 6.12 Dr. Willmar Schwabe GmbH
- 6.12.1 Dr. Willmar Schwabe GmbH Company Information
- 6.12.2 Dr. Willmar Schwabe GmbH Business Overview
- 6.12.3 Dr. Willmar Schwabe GmbH Cold and Flu Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Dr. Willmar Schwabe GmbH Cold and Flu Supplement Product Portfolio
- 6.12.5 Dr. Willmar Schwabe GmbH Recent Developments
7 North America
- 7.1 North America Cold and Flu Supplement Market Size (2021-2032)
- 7.2 North America Cold and Flu Supplement Market Size by Type
- 7.2.1 North America Cold and Flu Supplement Market Size by Type (2021-2026)
- 7.2.2 North America Cold and Flu Supplement Market Size by Type (2027-2032)
- 7.2.3 North America Cold and Flu Supplement Market Share by Type (2021-2032)
- 7.3 North America Cold and Flu Supplement Market Size by Application
- 7.3.1 North America Cold and Flu Supplement Market Size by Application (2021-2026)
- 7.3.2 North America Cold and Flu Supplement Market Size by Application (2027-2032)
- 7.3.3 North America Cold and Flu Supplement Market Share by Application (2021-2032)
- 7.4 North America Cold and Flu Supplement Market Size by Country
- 7.4.1 North America Cold and Flu Supplement Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Cold and Flu Supplement Market Size by Country (2021-2026)
- 7.4.3 North America Cold and Flu Supplement Market Size by Country (2027-2032)
- 7.4.4 North America Cold and Flu Supplement Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Cold and Flu Supplement Market Size (2021-2032)
- 8.2 Europe Cold and Flu Supplement Market Size by Type
- 8.2.1 Europe Cold and Flu Supplement Market Size by Type (2021-2026)
- 8.2.2 Europe Cold and Flu Supplement Market Size by Type (2027-2032)
- 8.2.3 Europe Cold and Flu Supplement Market Share by Type (2021-2032)
- 8.3 Europe Cold and Flu Supplement Market Size by Application
- 8.3.1 Europe Cold and Flu Supplement Market Size by Application (2021-2026)
- 8.3.2 Europe Cold and Flu Supplement Market Size by Application (2027-2032)
- 8.3.3 Europe Cold and Flu Supplement Market Share by Application (2021-2032)
- 8.4 Europe Cold and Flu Supplement Market Size by Country
- 8.4.1 Europe Cold and Flu Supplement Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Cold and Flu Supplement Market Size by Country (2021-2026)
- 8.4.3 Europe Cold and Flu Supplement Market Size by Country (2027-2032)
- 8.4.4 Europe Cold and Flu Supplement Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Cold and Flu Supplement Market Size (2021-2032)
- 9.2 China Cold and Flu Supplement Market Size by Type
- 9.2.1 China Cold and Flu Supplement Market Size by Type (2021-2026)
- 9.2.2 China Cold and Flu Supplement Market Size by Type (2027-2032)
- 9.2.3 China Cold and Flu Supplement Market Share by Type (2021-2032)
- 9.3 China Cold and Flu Supplement Market Size by Application
- 9.3.1 China Cold and Flu Supplement Market Size by Application (2021-2026)
- 9.3.2 China Cold and Flu Supplement Market Size by Application (2027-2032)
- 9.3.3 China Cold and Flu Supplement Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Cold and Flu Supplement Market Size (2021-2032)
- 10.2 Asia Cold and Flu Supplement Market Size by Type
- 10.2.1 Asia Cold and Flu Supplement Market Size by Type (2021-2026)
- 10.2.2 Asia Cold and Flu Supplement Market Size by Type (2027-2032)
- 10.2.3 Asia Cold and Flu Supplement Market Share by Type (2021-2032)
- 10.3 Asia Cold and Flu Supplement Market Size by Application
- 10.3.1 Asia Cold and Flu Supplement Market Size by Application (2021-2026)
- 10.3.2 Asia Cold and Flu Supplement Market Size by Application (2027-2032)
- 10.3.3 Asia Cold and Flu Supplement Market Share by Application (2021-2032)
- 10.4 Asia Cold and Flu Supplement Market Size by Country
- 10.4.1 Asia Cold and Flu Supplement Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Cold and Flu Supplement Market Size by Country (2021-2026)
- 10.4.3 Asia Cold and Flu Supplement Market Size by Country (2027-2032)
- 10.4.4 Asia Cold and Flu Supplement Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Cold and Flu Supplement Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Cold and Flu Supplement Market Size by Type
- 11.2.1 South America, Middle East & Africa Cold and Flu Supplement Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Cold and Flu Supplement Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Cold and Flu Supplement Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Cold and Flu Supplement Market Size by Application
- 11.3.1 South America, Middle East & Africa Cold and Flu Supplement Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Cold and Flu Supplement Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Cold and Flu Supplement Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Cold and Flu Supplement Market Size by Country
- 11.4.1 South America, Middle East & Africa Cold and Flu Supplement Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Cold and Flu Supplement Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Cold and Flu Supplement Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Cold and Flu Supplement Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst